Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of Recurrence.

Fasching PA, Kreipe H, Del Mastro L, Ciruelos E, Freyer G, Korfel A, Chouaki N, Stoffregen C, Sapunar F, Cameron D.